Lexicon Pharmaceuticals (LXRX) Interest Coverage Ratio (2010 - 2026)

Lexicon Pharmaceuticals (LXRX) has 17 years of Interest Coverage Ratio data on file, last reported at 0.23 in Q1 2026.

• On a quarterly basis, Interest Coverage Ratio rose 97.32% year-over-year to 0.23 in Q1 2026; TTM through Mar 2026 was 5.63, a 50.71% increase from a year earlier, with the FY2025 full-year figure at 4.2, down 796.92% from the prior year.
• Interest Coverage Ratio for Q1 2026 stood at 0.23, up from 7.28 in the prior quarter.
• Over the last five years, Interest Coverage Ratio for LXRX reached as high as 0.47 in Q2 2025 and fell as low as 212.55 in Q1 2022.
• Historically, Interest Coverage Ratio has averaged 22.94 across 5 years, with a median of 8.65 in 2025.
• Across the five-year window, Interest Coverage Ratio slumped 307.45% in 2024 and soared 101.89% in 2025, its largest moves.
• Year by year, Interest Coverage Ratio stood at 30.04 in 2022, then soared by 71.3% to 8.62 in 2023, then jumped by 34.36% to 5.66 in 2024, then fell by 28.6% to 7.28 in 2025, then surged by 96.82% to 0.23 in 2026.
• Per Business Quant data, the three most recent Interest Coverage Ratio figures were 0.23 in Q1 2026, 7.28 in Q4 2025, and 2.71 in Q3 2025.